Cargando…
RNase P Ribozymes Inhibit the Replication of Human Cytomegalovirus by Targeting Essential Viral Capsid Proteins
An engineered RNase P-based ribozyme variant, which was generated using the in vitro selection procedure, was used to target the overlapping mRNA region of two proteins essential for human cytomegalovirus (HCMV) replication: capsid assembly protein (AP) and protease (PR). In vitro studies showed tha...
Autores principales: | Yang, Zhu, Reeves, Michael, Ye, Jun, Trang, Phong, Zhu, Li, Sheng, Jingxue, Wang, Yu, Zen, Ke, Wu, Jianguo, Liu, Fenyong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4517104/ https://www.ncbi.nlm.nih.gov/pubmed/26114473 http://dx.doi.org/10.3390/v7072775 |
Ejemplares similares
-
Engineered RNase P Ribozymes Effectively Inhibit Human Cytomegalovirus Gene Expression and Replication
por: Yang, Zhu, et al.
Publicado: (2014) -
Inhibition of human cytomegalovirus immediate early gene expression and growth by a novel RNase P ribozyme variant
por: Sun, Xu, et al.
Publicado: (2017) -
Effective Inhibition of Human Immunodeficiency Virus 1 Replication by Engineered RNase P Ribozyme
por: Zeng, Wenbo, et al.
Publicado: (2012) -
Engineered RNase P Ribozymes Effectively Inhibit the Infection of Murine Cytomegalovirus in Animals
por: Li, Wei, et al.
Publicado: (2018) -
Inhibition of Murine Cytomegalovirus Infection in Animals by RNase P-Associated External Guide Sequences
por: Li, Wei, et al.
Publicado: (2017)